New patent for Esperion Theraps drug NEXLIZET

   October 16, 2021    Comments Off on New patent for Esperion Theraps drug NEXLIZET    Posted in: Patent Added

Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. There are six patents protecting this drug. NEXLIZET drug…

The post New patent for Esperion Theraps drug NEXLIZET appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog